drugset / Trial / NCT04197349
Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of this study is to determine the safety, tolerability and pharmacokinetics of ALD1910, a monoclonal antibody, administered by intravenous infusion and subcutaneous injection.
Timeline
- Start
- 2019-09-24
- Primary completion
- 2020-08-19
- Completion
- 2020-08-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALD1910 | Monoclonal antibody | — | Intravenous |
| Subject | Sumatriptan | Unknown | — | Subcutaneous |